Application 020541
- Type
- NDA
- Sponsor
- ANI PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARIMIDEX | ANASTROZOLE | TABLET;ORAL | 1MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0310-0201 | ARIMIDEX | Anastrozole | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 62559-670 | ARIMIDEX | Anastrozole | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-670 | ARIMIDEX | Anastrozole | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-670 | ARIMIDEX | Anastrozole | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-670 | ARIMIDEX | Anastrozole | ANI Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80620 | SUPPL | 2024-12-18 |
| 80603 | SUPPL | 2024-12-17 |
| 63853 | ORIG | 2020-01-01 |
| 57660 | ORIG | 2019-02-15 |
| 57144 | SUPPL | 2019-01-09 |
| 56877 | SUPPL | 2018-12-20 |
| 54293 | SUPPL | 2018-05-22 |
| 54292 | SUPPL | 2018-05-22 |
| 54291 | SUPPL | 2018-05-22 |
| 53731 | SUPPL | 2018-04-18 |
| 12705 | SUPPL | 2014-05-06 |
| 2698 | SUPPL | 2014-05-06 |
| 12704 | SUPPL | 2013-05-09 |
| 2697 | SUPPL | 2013-05-07 |
| 25144 | SUPPL | 2011-04-20 |
| 34805 | SUPPL | 2011-04-18 |
| 12703 | SUPPL | 2009-05-11 |
| 12702 | SUPPL | 2009-05-11 |
| 25143 | SUPPL | 2009-05-06 |
| 2696 | SUPPL | 2009-05-06 |
| 34804 | SUPPL | 2009-01-02 |
| 34803 | SUPPL | 2009-01-02 |
| 12701 | SUPPL | 2009-01-02 |
| 25142 | SUPPL | 2008-12-18 |
| 25141 | SUPPL | 2008-12-18 |
| 12700 | SUPPL | 2005-09-22 |
| 2695 | SUPPL | 2005-09-22 |
| 34802 | SUPPL | 2004-09-03 |
| 2694 | SUPPL | 2004-09-03 |
| 41419 | SUPPL | 2004-05-27 |
| 41420 | SUPPL | 2003-07-08 |
| 25139 | SUPPL | 2002-10-07 |
| 25140 | SUPPL | 2002-09-05 |
| 12699 | SUPPL | 2002-09-05 |
| 12698 | SUPPL | 2000-09-01 |
| 2693 | SUPPL | 2000-09-01 |